ATAI Life Sciences 
ATAI, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, is fast approaching my selected historical simple moving average (SMA). Often, but not always, the closer the price gets to this line, the higher chance there is for a fast upward move. In anticipation of this move, ATAI is in a personal buy zone at $1.30.
A word of caution: this is a pure technical analysis play and this company is not expected to be profitable for many, many years...
Target #1 = $1.75
Target #2 = $2.50
Target #3 = $2.95
ATAI, a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, is fast approaching my selected historical simple moving average (SMA). Often, but not always, the closer the price gets to this line, the higher chance there is for a fast upward move. In anticipation of this move, ATAI is in a personal buy zone at $1.30.A word of caution: this is a pure technical analysis play and this company is not expected to be profitable for many, many years...
Target #1 = $1.75
Target #2 = $2.50
Target #3 = $2.95
交易進行
Target #1 reached for a 34.6% gain.交易結束：目標達成
Target #2 reached for a 92.3% gain. While there still may room to run for my third target, I am going to close the trade, take profits, and wait for another future reentry opportunity.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。